REVIEW: Ahhhh what a satisfying book. Lethal Intent by Cara Putnam was so good. It had it all. 

If you know me at all, you know I love anything medical. This book certainly satisfied that for me. Caroline is legal counsel for a company that is developing genetic therapies. Right up my alley. 

Her love interest is Brandon. Yup. I love a good love story. Don’t you? 

Murder. Oh yeah! Not one but three! Who did it? You have to read the book to find out. 

Do you love legal thrillers? I do! 

There was so much to like about this book. If you like any one thing I mentioned, you will like this book. Her writing is easy to follow even when there is a lot going on. It wasn’t confusing. You need to try Cara Putnam. 

I received a copy of this book from the publisher for a fair and honest review.

SYNOPSIS: If they expected silence, they hired the wrong woman. 

Caroline Bragg’s life has never been better. She and Brandon Lancaster are taking their relationship to the next level, and she has a new dream job as legal counsel for Praecursoria—a research lab that is making waves with its cutting-edge genetic therapies. The company’s leukemia treatments even promise to save desperately sick kids—kids like eleven-year-old Bethany, a critically ill foster child at Brandon’s foster home. 

When Caroline’s enthusiastic boss wants to enroll Bethany in experimental trials prematurely, Caroline objects, putting her at odds with her colleagues. They claim the only goal at Praecursoria is to save lives. But does someone have another agenda? 

Brandon faces his own crisis. As laws governing foster homes shift, he’s on the brink of losing the group home he’s worked so hard to build. When Caroline learns he’s a Praecursoria investor, it becomes legally impossible to confide in him. Will the secrets she keeps become a wedge that separates them forever? And can she save Bethany from the very treatments designed to heal her? 

This latest romantic legal thriller by bestseller Cara Putman shines a light on the shadowy world of scientific secrets and corporate vendettas—and the ethical dilemmas that plague the place where science and commerce meet.